Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepavax-Gene TF vs Engerix-B in Prevention of Maternal-Infant HBV Transmission
CTR20140125Phase 3Completed
- Sponsor
- Tigermed
- Start
- Oct 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis b vaccine (recombinant) in hepatitis B (HBV), sponsored by Tigermed. Started Oct 2015; status: completed.
02
Drugs
hepatitis b vaccine (recombinant)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on CTR20140125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140125.